Lamotrigine Syrimed

Lamotrigine, the active ingredient in Lamotrigine Syrimed, is an antiepileptic presented as an oral formulation for oral use. It treats epilepsy and bipolar disorder in adults and children as prescribed.\n\nGNH India supplies Lamotrigine Syrimed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamotrigine is an antiepileptic drug that modulates neuronal excitability in seizure‑related and mood‑stabilizing pathways.\n\nEpilepsy: reduces the frequency of partial and generalized seizures.\nBipolar disorder: helps maintain mood stability and prevents depressive or manic episodes.

Lamotrigine may cause a range of adverse reactions, from mild to severe.\n\nCommon Side Effects:\n- Headache: mild to moderate pain often reported.\n- Dizziness: sensation of light‑headedness or unsteadiness.\n- Nausea: occasional stomach upset.\n- Rash: mild skin irritation or redness.\n- Fatigue: feeling unusually tired.\n- Insomnia: difficulty falling or staying asleep.\n\nSerious or Rare Side Effects:\n- Stevens‑Johnson syndrome: severe skin reaction requiring immediate medical attention.\n- Aseptic meningitis: inflammation of the meninges without infection.\n- Blood dyscrasias: abnormal blood cell counts.\n- Hepatotoxicity: liver enzyme elevations or injury.\n- Severe hypersensitivity: swelling, fever, or organ involvement.

Lamotrigine requires careful monitoring and specific handling to ensure safety and efficacy.\n\nDose titration: increase gradually as directed by a prescriber to reduce rash risk.\nPregnancy: discuss potential risks with a healthcare professional before use.\nRenal impairment: dose may need adjustment in reduced kidney function.\nConcomitant valproate: avoid unless specifically instructed, as it raises lamotrigine levels.\nDrug‑induced rash: discontinue immediately if a severe rash develops.\nStore at ambient temperature: keep below 25°C in the original container, protect from moisture and light.

Lamotrigine interacts with several medicines that can alter its plasma concentration or increase adverse effects.\n\nMajor Interactions (Avoid):\n- Valproic acid: markedly increases lamotrigine levels, risk of toxicity.\n- Carbamazepine: reduces lamotrigine levels, may diminish efficacy.\n\nModerate Interactions (Monitor Closely):\n- Oral contraceptives: may lower lamotrigine concentrations, requiring dose adjustment.\n- Phenobarbital: modestly decreases lamotrigine levels.\n- Phenytoin: may reduce lamotrigine exposure.\n- Serotonergic agents: monitor for additive CNS effects.